Aurobindo Pharma Ltd

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 201903 Annual Report Page No: 147)

  • Market Cap: 43,594 Cr.
  • Current Price: 744.00
  • 52 weeks High / Low 791.00 / 281.15
  • Book Value: 222.30
  • Stock P/E: 23.28
  • Dividend Yield: 0.40 %
  • ROCE: 14.92 %
  • ROE: 14.42 %
  • Sales Growth (3Yrs): 10.21 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Cons:
The company has delivered a poor growth of 11.51% over past five years.
Company has high debtors of 155.79 days.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
2,188 3,074 2,686 2,355 2,559 3,170 3,248 3,281 3,079 3,222 3,346 3,620
1,700 2,035 2,022 1,877 2,162 2,563 2,650 2,546 2,528 2,590 2,694 2,772
Operating Profit 489 1,039 664 478 397 607 598 734 550 631 651 849
OPM % 22% 34% 25% 20% 16% 19% 18% 22% 18% 20% 19% 23%
Other Income 12 29 34 6 3 4 137 28 30 34 38 161
Interest 10 12 13 17 24 31 41 35 32 25 21 17
Depreciation 83 90 90 92 94 101 109 109 115 118 119 119
Profit before tax 407 966 595 375 282 479 585 618 433 522 549 873
Tax % 24% 22% 25% 18% 20% 21% 21% 26% 24% 24% 24% 17%
Net Profit 307 753 444 308 225 381 464 460 330 398 419 725
EPS in Rs 5.25 12.85 7.58 5.26 3.84 6.50 7.91 7.85 5.64 6.80 7.15 12.37
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
2,276 2,749 3,195 4,130 4,277 5,424 7,108 8,069 9,158 9,607 10,270 12,258 13,266
1,917 2,500 2,497 3,173 3,704 4,466 5,187 5,816 6,705 7,215 7,600 9,838 10,585
Operating Profit 359 250 698 957 573 958 1,922 2,253 2,453 2,392 2,670 2,420 2,681
OPM % 16% 9% 22% 23% 13% 18% 27% 28% 27% 25% 26% 20% 20%
Other Income 119 75 172 29 -300 27 73 65 187 118 81 189 262
Interest 59 81 63 55 268 250 289 132 229 45 53 231 96
Depreciation 75 82 95 125 143 171 186 245 263 286 355 413 470
Profit before tax 345 161 712 805 -138 563 1,519 1,940 2,148 2,179 2,343 1,965 2,378
Tax % 16% 20% 26% 26% 69% 12% 23% 22% 24% 22% 23% 22%
Net Profit 291 129 526 594 -43 496 1,172 1,516 1,627 1,707 1,813 1,530 1,873
EPS in Rs 5.35 2.32 9.35 2.01 0.00 8.40 19.85 25.53 27.80 28.73 30.94 26.11 31.96
Dividend Payout % 6% 19% 5% 10% -68% 9% 7% 9% 9% 9% 8% 10%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:16.12%
5 Years:11.51%
3 Years:10.21%
TTM:8.23%
Compounded Profit Growth
10 Years:28.53%
5 Years:5.56%
3 Years:-1.87%
TTM:22.42%
Stock Price CAGR
10 Years:24.77%
5 Years:2.94%
3 Years:7.13%
1 Year:20.12%
Return on Equity
10 Years:22.18%
5 Years:21.44%
3 Years:18.42%
Last Year:14.42%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
27 27 28 29 29 29 29 29 59 59 59 59 59
Reserves 1,194 1,294 1,886 2,540 2,464 2,910 3,983 5,330 6,807 8,378 9,924 11,292 12,967
Borrowings 1,756 2,115 1,945 2,318 2,794 2,782 2,925 3,285 4,165 3,054 3,719 4,520 3,730
518 599 735 954 704 1,103 1,638 1,582 1,534 1,533 2,092 2,270 2,779
Total Liabilities 3,494 4,034 4,594 5,841 5,991 6,825 8,576 10,226 12,566 13,023 15,794 18,141 19,535
827 873 1,045 1,350 1,627 2,012 1,938 2,190 2,568 3,212 3,393 4,150 4,365
CWIP 125 286 499 537 558 166 204 227 742 907 1,144 789 727
Investments 288 269 371 493 629 708 873 1,013 1,183 1,682 1,968 2,339 2,520
2,255 2,606 2,678 3,461 3,177 3,938 5,561 6,796 8,072 7,222 9,289 10,863 11,924
Total Assets 3,494 4,034 4,594 5,841 5,991 6,825 8,576 10,226 12,566 13,023 15,794 18,141 19,535

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
105 5 346 245 504 625 328 590 2,457 922 527
-12 -302 -408 -569 -534 -295 -401 -624 -1,542 -991 -1,297
-185 161 -14 443 -78 -229 -31 35 -1,329 440 599
Net Cash Flow -92 -136 -75 118 -108 101 -105 1 -414 371 -171

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 14% 7% 21% 20% 9% 15% 29% 27% 24% 20% 19% 15%
Debtor Days 128 147 132 131 122 116 153 168 175 143 159 156
Inventory Turnover 2.26 2.34 2.08 2.00 2.03 2.27 2.22 1.96 1.87 1.91 1.56 1.67